Gunderson Capital Management Inc. Abbott Laboratories Transaction History

Gunderson Capital Management Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$102.07 - $123.37 $1.23 Million - $1.49 Million	-12,053 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$108.84 - $128.23 $197,653 - $232,865	1,816 Added 17.74%	12,053 $1.45 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $86,100 - $93,824	820 Added 8.71%	10,237 $1.12 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $69,371 - $84,246	757 Added 8.74%	9,417 $1.02 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $40,122 - $51,352	524 Added 6.44%	8,660 $792,000
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $140,528 - $205,490	2,237 Added 37.92%	8,136 $642,000
Q4 2019 Jan 31, 2020	BUY	$78.51 - $87.4 $199,729 - $222,345	2,544 Added 75.83%	5,899 $512,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $4,992 - $5,413	61 Added 1.85%	3,355 $281,000
Q2 2019 Nov 14, 2019	SELL	$72.88 - $85.0 $18,220 - $21,250	-250 Reduced 7.05%	3,294 $277,000
Q1 2019 Nov 14, 2019	BUY	$66.22 - $80.06 $28,275 - $34,185	427 Added 13.7%	3,544 $283,000
Q4 2018 Nov 14, 2019	BUY	$65.56 - $74.27 $204,350 - $231,499	3,117 New	3,117 $225,000

3,265

1.31B

9.64M

8.27M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $230B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Gunderson Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Gunderson Capital Management Inc. with notifications on news.